The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
Breast cancer is a complex disease that is one of the leading causes of cancer-related mortality in women worldwide. Of the subtypes of breast cancer, the most aggressive subtype is triple negative breast cancer (TNBC) due to its lack of targets that could be leveraged for treatment in other subtype...
Saved in:
| Main Authors: | Franklin Eduardo Corea-Dilbert, Muhammad Zubair Afzal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Onco |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-7523/5/2/18 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancer
by: Monika Drobniene, et al.
Published: (2025-04-01) -
Ferroptosis-related gene signature-based subtype identification of triple-negative breast cancer to prioritize treatment strategies
by: Yongzhen Chen, et al.
Published: (2025-05-01) -
The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01) -
Chemoimmunomodulation in triple negative breast cancer: a key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy
by: Mohammed O. Gbadamosi, et al.
Published: (2025-12-01) -
Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)